Proposed Data Collections Submitted for Public Comment and Recommendations, 35489-35490 [E7-12504]

Download as PDF 35489 Federal Register / Vol. 72, No. 124 / Thursday, June 28, 2007 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description [60 Day–07–07BD] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Building Related Asthma Research in Public Schools—New—National The mission of the National Institute for Occupational Safety and Health (NIOSH) is to promote safety and health at work for all people through research and prevention. The Occupational Safety and Health Act, Public Law 91– 596 (section 20[a][1]) authorizes the National Institute for Occupational Safety and Health (NIOSH) to conduct research to advance the health and safety of workers. NIOSH is conducting a longitudinal study among teachers and staff in public schools. The goals of this study are (1) To document the time course of changes in respiratory health, sick leave, and quality of life in relation to building remediation for water incursion and dampness problems and (2) to validate the reporting of buildingrelated lower respiratory symptoms in school staff with bronchial hyperresponsiveness by the use of serial spirometry to look for building-related patterns of airflow variability. The Centers for Disease Control and Prevention sponsored the Institute of Medicine to make an exhaustive review of the published literature relating exposures in damp buildings to health consequences. The committee findings, summarized in Damp Indoor Spaces and Health (Institute of Medicine of the National Academies of Science 2004), concluded that sufficient evidence exists for associating the presence of mold or other agents in damp buildings to nasal and throat symptoms, cough, wheeze, asthma symptoms in sensitized asthmatics, and hypersensitivity pneumonitis in susceptible persons. Identification of specific causal agents for these health outcomes in damp environments requires more investigation, and more research and demonstration projects are needed to evaluate interventions in damp buildings. NIOSH is proposing to conduct an initial cross-sectional respiratory health survey in three schools. The study will then continue with two additional years of longitudinal follow-up, which will be used to assess respiratory health and environmental conditions in relation to time and intervention status in the three schools. NIOSH will study one school with no history of building leaks and good control of internal moisture sources, one school with previous building leaks and water damage but with subsequent renovation before the start of the study, and one school with current building leaks and dampness problems with renovation scheduled during the study. The questionnaire will be administered each year to approximately 255 respondents by an interviewer who will record the responses directly into a computer. It will include sections on the participant’s medical history, work history, and home environment. All participants from the initial crosssectional survey meeting an epidemiologic definition of asthma and reporting that the symptoms improve away from the school will be asked to perform spirometry and a methacholine challenge test, or if obstructed, a bronchodilator test, both of which are standard medical tests for asthma; NIOSH anticipates about 45 respondents for these tests. Of those 45, 20 participants who are positive for either test will also be asked to participate in the serial spirometry study, which will cover three weeks during the school term and an additional three weeks during the summer break. Participation in all surveys is completely voluntary. There are no costs to the respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Number of responses per respondent Average burden per response (in hours) Total Burden (in hours) 255 25 20 1 1 1 1 2 39 255 50 780 Total .................................................................................................. mstockstill on PROD1PC66 with NOTICES Health questionnaire ................................................................................ Health questionnaire and lung function testing ....................................... Health questionnaire, lung function testing, serial spirometry ................ .......................... .......................... .......................... 1,085 VerDate Aug<31>2005 18:23 Jun 27, 2007 Jkt 211001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\28JNN1.SGM 28JNN1 35490 Federal Register / Vol. 72, No. 124 / Thursday, June 28, 2007 / Notices Dated: June 22, 2007. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–12504 Filed 6–27–07; 8:45 am] BILLING CODE 4163–18–P gonorrhea in the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2006 and to release an MMWR article stating the CDC no longer recommended fluoroquinolones for treatment of gonococcal infections (CDC, MMWR, Vol. 56, No. 14, 332– 336). Under the GISP protocol, clinics are asked to provide 25 isolates per month. However, due to low volume at some sites, clinics submit an average of 20 isolates per clinic per month, providing an average of 121 isolates per laboratory per month. For Forms 1 and 2, a ‘‘response’’ is defined as the laboratory processing and data collection/ processing associated with an individual gonococcal isolate from an individual patient. The estimated time for clinical personnel to abstract data for Form 1 is 11 minutes per response (20 isolates per clinic per month; the total number of responses per 30 clinics is 240). Based on previous laboratory experience in analyzing the gonococcal isolates, the estimated burden for each participating laboratory for Form 2 is 1 hour per response, which includes the time required for laboratory processing of the client’s isolate, gathering and maintaining the data needed, and completing and reviewing the collection of information. We estimate 121 gonococcal isolates per laboratory each month (total number of responses per 5 laboratories is 1,452). For Form 3, a ‘‘response’’ is defined as the laboratory processing and recording of laboratory data for a set of 7 control strains. It takes approximately 12 minutes to process and record the laboratory data on Form 3 for one set of 7 control strains, of which there are 4 sets (total number of responses per 5 laboratories is 48). There is no cost to respondents other than their time. or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project The Gonococcal Isolate Surveillance Project (GISP) (OMB No. 0920–0307)— Extension—National Center for HIV/ AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). DEPARTMENT OF HEALTH AND HUMAN SERVICES [60 Day–07–0307] Centers for Disease Control and Prevention; Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 or send comments to Maryam Daneshvar, Acting CDC Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques Background and Brief Description The objectives of GISP are: (1) To monitor trends in antimicrobial susceptibility of strains of Neisseria gonorrhoeae in the United States and (2) to characterize resistant isolates. GISP provides critical surveillance for antimicrobial resistance, allowing for informed treatment recommendations. GISP was established in 1986 as a voluntary surveillance project and now involves 5 regional laboratories and 30 publicly funded sexually transmitted disease clinics around the country. The STD clinics submit up to 25 gonococcal isolates per month to the regional laboratories, which measure susceptibility to a panel of antibiotics. Limited demographic and clinical information corresponding to the isolates are submitted directly by the clinics to CDC. During 1986–2006, GISP has demonstrated the ability to effectively achieve its objectives. The emergence of resistance in the United States to penicillin, tetracyclines, and now fluoroquinolones was identified through GISP and makes ongoing surveillance critical. Increased prevalence of fluoroquinolone-resistant N. gonorrhoeae (QRNG) as seen in GISP data has prompted the CDC to update the treatment recommendations for ESTIMATE OF ANNUALIZED BURDEN HOURS Clinic: Form 1 ...................................................................................................... Laboratory: Form 2 ...................................................................................................... Form 3 ...................................................................................................... mstockstill on PROD1PC66 with NOTICES Total ................................................................................................... VerDate Aug<31>2005 18:23 Jun 27, 2007 Jkt 211001 PO 00000 Number of responses per respondent Number of respondents Types of forms Frm 00069 Fmt 4703 Average burden per response (in hours) Total burden (in hours) 30 240 11/60 1,320 5 5 1,452 48 1 12/60 7,260 48 ........................ ........................ ........................ 8,628 Sfmt 4703 E:\FR\FM\28JNN1.SGM 28JNN1

Agencies

[Federal Register Volume 72, Number 124 (Thursday, June 28, 2007)]
[Notices]
[Pages 35489-35490]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-12504]



[[Page 35489]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-07-07BD]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Building Related Asthma Research in Public Schools--New--National 
Institute for Occupational Safety and Health (NIOSH), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    The mission of the National Institute for Occupational Safety and 
Health (NIOSH) is to promote safety and health at work for all people 
through research and prevention. The Occupational Safety and Health 
Act, Public Law 91-596 (section 20[a][1]) authorizes the National 
Institute for Occupational Safety and Health (NIOSH) to conduct 
research to advance the health and safety of workers. NIOSH is 
conducting a longitudinal study among teachers and staff in public 
schools. The goals of this study are (1) To document the time course of 
changes in respiratory health, sick leave, and quality of life in 
relation to building remediation for water incursion and dampness 
problems and (2) to validate the reporting of building-related lower 
respiratory symptoms in school staff with bronchial hyper-
responsiveness by the use of serial spirometry to look for building-
related patterns of airflow variability.
    The Centers for Disease Control and Prevention sponsored the 
Institute of Medicine to make an exhaustive review of the published 
literature relating exposures in damp buildings to health consequences. 
The committee findings, summarized in Damp Indoor Spaces and Health 
(Institute of Medicine of the National Academies of Science 2004), 
concluded that sufficient evidence exists for associating the presence 
of mold or other agents in damp buildings to nasal and throat symptoms, 
cough, wheeze, asthma symptoms in sensitized asthmatics, and 
hypersensitivity pneumonitis in susceptible persons. Identification of 
specific causal agents for these health outcomes in damp environments 
requires more investigation, and more research and demonstration 
projects are needed to evaluate interventions in damp buildings.
    NIOSH is proposing to conduct an initial cross-sectional 
respiratory health survey in three schools. The study will then 
continue with two additional years of longitudinal follow-up, which 
will be used to assess respiratory health and environmental conditions 
in relation to time and intervention status in the three schools. NIOSH 
will study one school with no history of building leaks and good 
control of internal moisture sources, one school with previous building 
leaks and water damage but with subsequent renovation before the start 
of the study, and one school with current building leaks and dampness 
problems with renovation scheduled during the study. The questionnaire 
will be administered each year to approximately 255 respondents by an 
interviewer who will record the responses directly into a computer. It 
will include sections on the participant's medical history, work 
history, and home environment. All participants from the initial cross-
sectional survey meeting an epidemiologic definition of asthma and 
reporting that the symptoms improve away from the school will be asked 
to perform spirometry and a methacholine challenge test, or if 
obstructed, a bronchodilator test, both of which are standard medical 
tests for asthma; NIOSH anticipates about 45 respondents for these 
tests. Of those 45, 20 participants who are positive for either test 
will also be asked to participate in the serial spirometry study, which 
will cover three weeks during the school term and an additional three 
weeks during the summer break. Participation in all surveys is 
completely voluntary. There are no costs to the respondents other than 
their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                  Number of      Average burden
                  Form name                      Number of      responses per     per response     Total Burden
                                                respondents       respondent       (in hours)       (in hours)
----------------------------------------------------------------------------------------------------------------
Health questionnaire........................              255                1                1              255
Health questionnaire and lung function                     25                1                2               50
 testing....................................
Health questionnaire, lung function testing,               20                1               39              780
 serial spirometry..........................
                                             -------------------------------------------------------------------
    Total...................................  ...............  ...............  ...............            1,085
----------------------------------------------------------------------------------------------------------------



[[Page 35490]]

    Dated: June 22, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E7-12504 Filed 6-27-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.